APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -7.5% | 10,998 | +121.6% | 0.03% | -11.1% |
| Q2 2023 | $452 | +10.5% | 4,963 | -20.0% | 0.04% | +20.0% |
| Q1 2023 | $409 | -8.1% | 6,207 | -27.9% | 0.03% | -18.9% |
| Q4 2022 | $445 | -99.9% | 8,604 | +22.0% | 0.04% | -17.8% |
| Q3 2022 | $482,000 | 0.0% | 7,050 | -33.8% | 0.04% | +2.3% |
| Q2 2022 | $482,000 | +53.0% | 10,651 | +71.9% | 0.04% | +340.0% |
| Q1 2022 | $315,000 | – | 6,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |